Related references
Note: Only part of the references are listed.Characteristics of relapse after autologous stem-cell transplantation for follicular lymphoma: a long-term follow-up
M. Kornacker et al.
ANNALS OF ONCOLOGY (2009)
Unrelated Donor Hematopoietic Cell Transplantation for Non-Hodgkin Lymphoma: Long-Term Outcomes
Koen van Besien et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2009)
TLI and ATG conditioning with low risk of graft-versus-host disease retains antitumor reactions after allogeneic hematopoietic cell transplantation from related and unrelated donors
Holbrook E. Kohrt et al.
BLOOD (2009)
Favorable overall survival with fully myeloablative allogeneic stem cell transplantation for follicular lymphoma
John Kuruvilla et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2008)
Allogeneic transplantation with reduced-intensity conditioning for Hodgkin and non-Hodgkin lymphoma: Importance of histology for outcome
Philippe Armand et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2008)
Allogeneic transplants in follicular lymphoma: Higher risk of disease progression after reduced-intensity compared to myeloablative conditioning
Parameswaran Hari et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2008)
Eight-year experience with allogeneic stem cell transplantation for relapsed follicular lymphoma after nonmyeloablative conditioning with fludarabine, cyclophosphamide, and rituximab
Issa F. Khouri et al.
BLOOD (2008)
Outcome of BEAM-autologous and BEAM-alemtuzumab allogeneic transplantation in relapsed advanced stage follicular lymphoma
Wendy Ingram et al.
BRITISH JOURNAL OF HAEMATOLOGY (2008)
Improved Survival in Lymphoma Patients Receiving Sirolimus for Graft-Versus-Host Disease Prophylaxis After Allogeneic Hematopoietic Stem-Cell Transplantation With Reduced-Intensity Conditioning
Philippe Armand et al.
JOURNAL OF CLINICAL ONCOLOGY (2008)
Nonmyeloablative allogeneic hematopoietic cell transplantation in relapsed, refractory, and transformed indolent non-Hodgkin's lymphoma
Andrew R. Rezvani et al.
JOURNAL OF CLINICAL ONCOLOGY (2008)
Outcomes after allogenic hematopoietic cell transplantation with nonmyeloablative or myeloablative conditioning regimens for treatment of lymphoma and chronic lymphocytic leukemia
Mohamed L. Sorror et al.
BLOOD (2008)
Late mortality after allogeneic hematopoietic cell transplantation and functional status of long-term survivors: report from the Bone Marrow Transplant Survivor Study
Smita Bhatia et al.
BLOOD (2007)
Long-term outcomes after reduced-intensity conditioning allogeneic stem cell transplantation for low-grade lymphoma:: a survey by the French Society of Bone Marrow Graft Transplantation and Cellular Therapy (SFGM-TC)
Stephane Vigouroux et al.
HAEMATOLOGICA-THE HEMATOLOGY JOURNAL (2007)
Comparison of reduced-intensity and conventional myeloablative regimens for allogeneic transplantation in non-Hodgkin's lymphoma
Roberto Rodriguez et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2006)
Performance status and comorbidity predict transplant-related mortality after allogeneic hematopoietic cell transplantation
Andrew S. Artz et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2006)
Improving the efficacy of reduced intensity allogeneic transplantation for lymphoma using radioimmunotherapy
Ajay K. Gopal et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2006)
Comparative outcome of reduced intensity and myeloablative conditioning regimen in HLA identical sibling allogeneic haematopoietic stem cell transplantation for patients older than 50 years of age with acute myeloblastic leukaemia: a retrospective survey from the Acute Leukemia Working Party (ALWP) of the European group for Blood and Marrow Transplantation (EBMT)
M Aoudjhane et al.
LEUKEMIA (2005)
Donor lymphocyte infusions can result in sustained remissions in patients with residual or relapsed lymphoid malignancy following allogeneic haemopoietic stem cell transplantation
NH Russell et al.
BONE MARROW TRANSPLANTATION (2005)
Comparative outcome of nonmyeloablative and myeloablative allogeneic hematopoietic cell transplantation for patients older than 50 years of age
EP Alyea et al.
BLOOD (2005)
Morbidity and mortality with nonmyeloablative compared with myeloablative conditioning before hematopoietic cell transplantation from HLA-matched related donors
R Diaconescu et al.
BLOOD (2004)
Outcomes after alemtuzumab-containing reduced-intensity allogeneic transplantation regimen for relapsed and refractory non-Hodgkin lymphoma
E Morris et al.
BLOOD (2004)
Comparison of autologous and allogeneic hematopoietic stem cell transplantation for follicular lymphoma
K van Besien et al.
BLOOD (2003)
Syngeneic hematopoietic stem-cell transplantation for Non-Hodgkin's lymphoma: A comparison with allogeneic and autologous transplantation - The lymphoma working committee of the International Bone Marrow Transplant Registry and the European Group for Blood and Marrow Transplantation
PJ Bierman et al.
JOURNAL OF CLINICAL ONCOLOGY (2003)
An EBMT registry matched study of allogeneic stem cell transplants for lymphoma: allogeneic transplantation is associated with a lower relapse rate but a higher procedure-related mortality rate than autologous transplantation
AJ Peniket et al.
BONE MARROW TRANSPLANTATION (2003)
Graft-versus-lymphoma effect of donor lymphocyte infusion in indolent lymphomas relapsed after allogeneic stem cell transplantation
CMPW Mandigers et al.
BONE MARROW TRANSPLANTATION (2003)
Chemoresistant or aggressive lymphoma predicts for a poor outcome following reduced-intensity allogeneic progenitor cell transplantation: an analysis from the Lymphoma Working Party of the European Group for Blood and Bone Marrow Transplantation
SP Robinson et al.
BLOOD (2002)
Allogeneic bone marrow transplantation for low-grade lymphoma and chronic lymphocytic leukemia
CL Toze et al.
BONE MARROW TRANSPLANTATION (2000)
Share Paper
